These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35317796)

  • 1. Correction to: Lifetime risk of cardiovascular-renal disease in type 2 diabetes: a population-based study in 473,399 individuals.
    Zhang R; Mamza JB; Morris T; Godfrey G; Asselbergs FW; Denaxas S; Hemingway H; Banerjee A
    BMC Med; 2022 Mar; 20(1):121. PubMed ID: 35317796
    [No Abstract]   [Full Text] [Related]  

  • 2. Lifetime risk of cardiovascular-renal disease in type 2 diabetes: a population-based study in 473,399 individuals.
    Zhang R; Mamza JB; Morris T; Godfrey G; Asselbergs FW; Denaxas S; Hemingway H; Banerjee A
    BMC Med; 2022 Feb; 20(1):63. PubMed ID: 35130878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.
    Kones R
    Drug Des Devel Ther; 2011; 5():325-80. PubMed ID: 21792295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study.
    Ligthart S; van Herpt TT; Leening MJ; Kavousi M; Hofman A; Stricker BH; van Hoek M; Sijbrands EJ; Franco OH; Dehghan A
    Lancet Diabetes Endocrinol; 2016 Jan; 4(1):44-51. PubMed ID: 26575606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term population-based trends in the incidence of cardiovascular disease in individuals with type 1 diabetes from Finland: a retrospective, nationwide, cohort study.
    Harjutsalo V; Pongrac Barlovic D; Groop PH
    Lancet Diabetes Endocrinol; 2021 Sep; 9(9):575-585. PubMed ID: 34303414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular health, genetic predisposition, and lifetime risk of type 2 diabetes.
    Wang K; Kavousi M; Voortman T; Ikram MA; Ghanbari M; Ahmadizar F
    Eur J Prev Cardiol; 2022 Jan; 28(16):1850-1857. PubMed ID: 34583386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of carotid intima-media thickness and carotid plaques on the development of micro- and macrovascular complications in individuals with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study.
    Cardoso CRL; Salles GC; Leite NC; Salles GF
    Cardiovasc Diabetol; 2019 Jan; 18(1):2. PubMed ID: 30630491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lifetime risk and years lived free of total cardiovascular disease.
    Wilkins JT; Ning H; Berry J; Zhao L; Dyer AR; Lloyd-Jones DM
    JAMA; 2012 Nov; 308(17):1795-801. PubMed ID: 23117780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating individual lifetime risk of incident cardiovascular events in adults with Type 2 diabetes: an update and geographical calibration of the DIAbetes Lifetime perspective model (DIAL2).
    Østergaard HB; Hageman SHJ; Read SH; Taylor O; Pennells L; Kaptoge S; Petitjean C; Xu Z; Shi F; McEvoy JW; Herrington W; Visseren FLJ; Wood A; Eliasson B; Sattar N; Wild S; Di Angelantonio E; Dorresteijn JAN
    Eur J Prev Cardiol; 2023 Jan; 30(1):61-69. PubMed ID: 36208182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifetime risk of cardiovascular disease among individuals with and without diabetes stratified by obesity status in the Framingham heart study.
    Fox CS; Pencina MJ; Wilson PW; Paynter NP; Vasan RS; D'Agostino RB
    Diabetes Care; 2008 Aug; 31(8):1582-4. PubMed ID: 18458146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of Lifetime Risk of Cardiovascular Disease Deaths Stratified by Sex in the Japanese Population.
    Imai Y; Mizuno Tanaka S; Satoh M; Hirata T; Murakami Y; Miura K; Waki T; Hirata A; Sairenchi T; Irie F; Sata M; Ninomiya T; Ohkubo T; Ishikawa S; Miyamoto Y; Ohnishi H; Saitoh S; Tamakoshi A; Yamada M; Kiyama M; Iso H; Sakata K; Nakagawa H; Okayama A; Ueshima H; Okamura T;
    J Am Heart Assoc; 2021 Dec; 10(23):e021753. PubMed ID: 34845914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired fasting glucose, type 2 diabetes mellitus, and lifetime risk of cardiovascular disease among women and men: the Rotterdam Study.
    Ahmadizar F; Wang K; Aribas E; Fani L; Heshmatollah A; Ikram MK; Kavousi M
    BMJ Open Diabetes Res Care; 2021 Aug; 9(1):. PubMed ID: 34433547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comprehensive Cardiovascular-Renal-Metabolic Risk Reduction Approach to Patients with Type 2 Diabetes Mellitus.
    Pagidipati NJ; Deedwania P
    Am J Med; 2021 Sep; 134(9):1076-1084. PubMed ID: 34029524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simulating lifetime outcomes associated with complications for people with type 1 diabetes.
    Lung TW; Clarke PM; Hayes AJ; Stevens RJ; Farmer A
    Pharmacoeconomics; 2013 Jun; 31(6):509-18. PubMed ID: 23585309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic susceptibility, obesity and lifetime risk of type 2 diabetes: The ARIC study and Rotterdam Study.
    Ligthart S; Hasbani NR; Ahmadizar F; van Herpt TTW; Leening MJG; Uitterlinden AG; Sijbrands EJG; Morrison AC; Boerwinkle E; Pankow JS; Selvin E; Ikram MA; Kavousi M; de Vries PS; Dehghan A
    Diabet Med; 2021 Oct; 38(10):e14639. PubMed ID: 34245042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility of serologic testing for celiac disease in asymptomatic patients: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2011; 11(3):1-63. PubMed ID: 23074415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Validation of a Lifetime Risk Model for Kidney Failure and Treatment Benefit in Type 2 Diabetes: 10-Year and Lifetime Risk Prediction Models.
    Østergaard HB; Read SH; Sattar N; Franzén S; Halbesma N; Dorresteijn JAN; Westerink J; Visseren FLJ; Wild SH; Eliasson B; van der Leeuw J
    Clin J Am Soc Nephrol; 2022 Dec; 17(12):1783-1791. PubMed ID: 36332974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a high dietary fiber cereal meal intervention on body weight, adipose distribution, and cardiovascular risk among individuals with type 2 diabetes.
    Li X; Shi Y; Wei D; Ni W; Zhu N; Yan X
    Front Endocrinol (Lausanne); 2023; 14():1283626. PubMed ID: 37964962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk and lifetime benefit from preventive treatment in type 2 diabetes: A post hoc analysis of the CAPTURE study.
    Østergaard HB; Humphreys V; Hengeveld EM; Honoré JB; Mach F; Visseren FLJ; Westerink J; Yadav G; Mosenzon O;
    Diabetes Obes Metab; 2023 Feb; 25(2):435-443. PubMed ID: 36199242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease: the coronary artery risk development in young adults study and multi-ethnic study of atherosclerosis.
    Berry JD; Liu K; Folsom AR; Lewis CE; Carr JJ; Polak JF; Shea S; Sidney S; O'Leary DH; Chan C; Lloyd-Jones DM
    Circulation; 2009 Jan; 119(3):382-9. PubMed ID: 19139385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.